Organoid models: reshaping the paradigm for precision development and evaluation of CAR-T cell therapies
{{output}}
Chimeric antigen receptor T (CAR-T) cell therapy has achieved transformative success in hematological malignancies; however, its translation to solid tumors remains severely limited by tumor heterogeneity, immunosuppressive microenvironments, and safety concer... ...
